Introduction
Although drug-eluting stents (DESs) have proved more effective in reducing restenosis than bare metal stents (BMSs), 1 DESs are not free of restenosis and are limited by stent thrombosis. 2 BMS restenosis usually occurs in the early phase (until 6 months) or, to a lesser extent, very late phase (beyond 4 years). Neointima after BMS implantation have been considered as stable. However, clinical and pathological studies demonstrated that atherosclerotic change can develop within the neointima of a BMS, leading to very late restenosis or late stent thrombosis of the BMS. 3, 4 Recently, Nakazawa et al. 4 reported that this phenomenon (neoatherosclerosis) is a frequent finding in DESs and occurs earlier than in BMSs. Restenosis of a DES may show a different time course from that of a BMS and occasionally occurs .1 year after stent implantation (i.e. late catch-up phenomenon). 5 -7 In addition, previous optical coherence tomography (OCT) reports showed various OCT image patterns of DES restenotic tissue being different from early BMS restenotic tissue. 6, 7 According to these reports, the mechanism and time course of DES restenosis might be different from that of BMS restenosis. To gain insight into the mechanisms and time course of DES restenosis, we evaluated the presence of numerous morphological characteristics as visualized with OCT, and compared these images between cases with early (,1 year), late (1-3 years), and very late (.3 years) restenotic lesions of first generation DESs (Cypher, Cordis Corp., Miami Lakes, FL, USA and Taxus, Boston Scientific, Natick, MA, USA, respectively).
Methods

Study design and population
Patients with first in-stent restenosis (ISR) of first generation DESs were enrolled in this study. ISR was defined as .50% of diameter stenosis within the stent segment. ISR was classified into early ISR (E-ISR), late ISR (L-ISR) or very late ISR (VL-ISR) to evaluate the time course of DES restenosis, as previously reported for BMS restenosis. E-ISR was defined as the first ISR observed within 1 year after stent implantation. 3 Patients with ISR after 1 year were divided into two groups (L-ISR and VL-ISR) using the median follow-up duration (3 years) in order to divide patient numbers with the detected late catch-up phenomenon equally. L-ISR was defined as the first ISR observed between 1 and 3 years after stent implantation, which was not detected at the first short-term follow-up angiography (within 1 year after stent implantation). 7 VL-ISR was defined as the first ISR observed .3 years after stent implantation and not detected at the previous follow-up angiography. Short-term follow-up angiography was performed due to: (i) the scheduled follow-up of the implanted stent; or (ii) evidence of myocardial ischaemia. Long-term follow-up angiography (.1 year) was performed due to: (i) the scheduled follow-up of other treated segment; or (ii) evidence of myocardial ischaemia. A prospective protocol was approved by the institutional review board to perform an OCT study in all patients with ISR on coronary angiography, provided patients met the eligibility criteria as well as had given written informed consent. Inclusion criteria consisted of patients: (i) with first ISR after first generation DES implantation on angiography; and (ii) amenable for OCT study. Exclusion criteria were: (i) left main coronary artery disease; (ii) totally occluded lesion; (iii) bifurcation stenting lesion; (iv) bypass graft lesion; (v) multiple stenting lesion; (vi) cardiogenic shock; (vii) left ventricular ejection fraction ,30%; (viii) serum creatinine .2 mg/dL and (ix) ST-elevation myocardial infarction. After diagnostic cardiac catheterization, patients who met the eligibility criteria were invited to participate in this study.
Quantitative coronary angiography
Off-line quantitative coronary angiography (QCA) was conducted using the view that revealed the highest degree of stenosis. The severity of coronary stenosis was measured using the Cardiovascular Measurement System (CMS-MEDIS Medical Imaging System, Leiden, The Netherlands). For every patient, angiograms were analysed at the time of OCT examination. Lesion length, reference diameter, minimal luminal diameter and percent diameter stenosis (%DS) were calculated by a single operator who was blinded to clinical characteristics. Analysis of angiographic frames was performed in the enddiastolic stage. The angiographic restenotic lesion type was classified as: focal restenosis : ,10 mm in length (IA: articulation or gap, IB: margin, IC: focal body, ID: multifocal) or diffuse restenosis : .10 mm in length (II: intra-stent, III: proliferative). 8 
OCT imaging
After completion of coronary angiography and before any intervention, patients were evaluated with OCT. OCT imaging was performed using the OCT imaging system (M2 OCT system, LightLab Imaging, Westford, MA, USA) using the occlusion balloon catheter (Helios, LightLab Imaging, Westford, MA, USA) method. The detailed specifications and the OCT procedure have been described elsewhere. 9 OCT quantitative and qualitative analysis OCT analysis was performed using the LightLab OCT imaging proprietary software (LightLab Imaging, Westford, MA, USA). Both qualitative and quantitative analyses of OCT images were performed by experienced analysts who were blinded to clinical and angiographic lesion characteristics. The following analyses, including lumen and stent areas or morphological appearance, were performed at 1 mm longitudinal steps throughout the pull-back from the distal stent edge to the proximal stent edge. At every frame, the lumen and stent were manually traced, and the neointimal hyperplasia (NIH) area (stent area 2 lumen area) was calculated. Percent NIH area was also calculated as (NIH area/stent area) × 100.
To evaluate the morphological appearance of the restenotic tissue, the pattern of restenotic tissue structure in the cross-sectional images at every 1 mm interval was categorized: (i) homogeneous intima: restenotic tissue has uniform optical properties and does not show focal variations in the backscattering pattern (Figure 1A) 10 ; or (ii) heterogeneous intima: heterogeneous intima was further categorized into four types: (i) type 1: thin-cap fibroatheroma (TCFA)-like pattern; presence of an area with marked signal attenuation with a diffuse border, and fibrous cap thickness at the thinnest part ≤65 mm and an angle of lipidic tissue ≥180 (Figure1B) 11, 12 ; (ii) type 2: layered pattern; restenotic tissue consists of concentric layers with different optical properties (thick high scattering layer and a low scattering layer with stent strut) (Figure1C) 9, 13 ; (iii) type 3: patchy pattern; patchy and highly echolucent regions throughout the layers (Figure1D) 14 or (iv) type 4: speckled pattern; restenotic tissue consists of a heterogeneous speckled band (Figure1E). 14 In addition, we also evaluated the peri-strut low intensity area (PLIA), defined as a region around stent struts with homogeneous lower intensity than the surrounding tissue on OCT images without signal attenuation ( Figure 1F ) 15, 16 and neovascularization, which was defined as small vesicular or tubular structures differentiated from any side branches with a diameter ,200 mm. Neovascularization was classified into intra-intima ( Figure 1G ) or peri-stent ( Figure 1H ) by the location of the microvessels. 9 Moreover, peri-stent ulcer-like appearance, defined as a hollow shape (.908/frame) in the vessel wall adjacent to the stent struts (Figure1I) 17 was also evaluated. The proportions of cross sections (CSs) per stent with the above described qualitative findings with respect to the total numbers of analysed CSs were reported. We also evaluated the presence of (i) disrupted intima (discontinuity of lumen border) with visible cavity ( Figure 1J To test for inter-observer variability of the qualitative OCT analysis, a total of 100 CSs within the restenotic lesions from 10 patients by each 10 CSs were selected and analysed independently by two observers not involved in the primary data analysis. One of the observers repeated the analysis 1 week later to assess the intra-observer variability.
Statistical analysis
Categorical variables are expressed as numbers (percentages). Continuous variables are expressed as mean + standard deviation. Comparisons between groups were performed with a one-way ANOVA test for continuous variables and with the x 2 test or Fisher's exact test for categorical variables. When the one-way ANOVA was significant, differences between series of data were determined using Tukey's test. The reproducibility of qualitative variables was assessed with a k-test. A P-value of ,0.05 was considered statistically significant. All statistical analysis was performed using SPSS software (SPSS, Inc., Chicago, IL, USA).
Results
Reproducibility of qualitative OCT analysis
Inter-/intra-observer variability (kappa values) for the qualitative OCT assessment was as follows: 0. 
Clinical characteristics
Clinical characteristics of the study population are listed in Table 1 . There were no significant differences between the groups except for the kind of stents implanted. About 90% of patients in VL-ISR were treated with the Cypher stent.
QCA analysis
QCA findings of the restenotic lesion, shown in Table 2 , revealed that there were no significant differences in any parameters and the restenotic pattern between the three groups. In addition, no patient presented with angiographic evidence of thrombus. 
OCT analysis
The results of OCT quantitative and qualitative analyses of the entire stent are shown in Table 3 and Figure 2 . Per lesion/stent, the proportions of CSs with the qualitative findings with respect to the total number of analysed CSs were reported. In the quantitative analysis of the entire stent, there were no significant differences in any parameter. In addition to a greater trend a Qualitative analysis in entire stent including restenotic tissue structure (homogeneous or heterogeneous), microvessels, peri-strut low intensity area, and peri-stent ulcer-like appearance were calculated as (numbers of cross-sections with the findings/numbers of analysed cross-sections) × 100.
for heterogeneous intima at the later phase, the TCFA-like pattern and intra-intima microvessels were more frequently observed in the VL-ISR group, whereas the speckled pattern image and PLIA were more frequently detected in the E-ISR group. TCFA-like pattern image and intra-intima microvessels were significantly increased from the early to the very late phase, whereas the speckled pattern image was significantly decreased from the early to the very late phase. Disrupted intima with cavity and intraluminal materials with shadowing were more frequently detected in the VL-ISR group.
Analysis at the minimum lumen area (MLA) site is shown in Table 4 and Figure 3 . Similar to the entire stent analysis, the TCFAlike image was more frequently observed in the VL-ISR group and the speckled pattern image was more frequently observed in the E-ISR group.
In addition, we compared the incidence of disrupted intima with cavity, intraluminal material, microvessels, and PLIA between each type of OCT images (homogeneous and classified four heterogeneous patterns) ( Table 5 ). The incidence of disrupted intima with visible cavity, intraluminal materials (with/without shadowing), and intraluminal microvessels was significantly higher in TCFA-like OCT images.
Discussion
The main findings of this study are as follows: (i) the qualitative OCT findings of DES restenosis tissue were significantly different between early, late, and very late restenosis phases; (ii) TCFAlike pattern image and intra-intima microvessels were increased from the early to the very late phase; and (iii) the speckled pattern image was decreased from the early to the very late phase.
OCT images in DES-ISR
Heterogeneous OCT images in DES-ISR lesions showed differential patterns similar to a previous report 9 and were categorized into four types. TCFA-like pattern image, which was also frequently observed in BMS VL-ISR (beyond 4 years after stent implantation) lesions as we have previously reported, 3 is similar to the morphology seen with typical de novo atherosclerosis lesions.
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In this current study, some findings (presumably related to atherosclerosis) including intra-intima microvessels (closely associated with plaque progression and plaque haemorrhage 18 ), intraluminal materials with shadowing (suggested a red thrombus, whereas that without shadowing suggested a white thrombus 19 ), and disrupted intima with cavity [similar to an atherosclerotic plaque rupture in acute coronary syndrome (ACS) patients] were more frequently detected in the VL-ISR group. Those findings were most frequently observed with the TCFA-like pattern image in this study (Figures 2 and 3) . Further, TCFA-like pattern image was significantly increased from the early to the very late phase, which had already been observed 1 year after DES implantation (Figure 2) . Assuming a correspondence between previously validated OCT characteristics of atherosclerotic plaques, our data suggest that the TCFA-like pattern image relate to neo-atherosclerosis in the DES and is associated with the mechanism of DES restenosis.
Previous pathological study
In their pathology study from autopsy cases, Nakazawa et al. 4 have
reported that neo-atherosclerosis was significantly more frequently observed in DES lesions (31%) than BMS lesions (16%; P , 0.001), and the median stent duration with neo-atherosclerosis was shorter in DES than BMS (DESs: 420 days; BMS: 2160 days, P , 0.001). Their histological results of neointima might support our hypothesis of neo-atherosclerosis in DESs. 
Comparisons with previous studies
Using OCT, Kang et al. 20 also reported neo-atherosclerosis of neointima in DES failure, especially late after implantation. With regard to the results, there is a difference (incidence of the TCFAlike image) between our and their data as follows: they showed that 70% of patients with late ISR (20 months after DES implantation) revealed the TCFA-like image, yet our data showed TCFAlike image in 50% of patients in the VL-ISR group and in 30% of the L-ISR group at the MLA site. Potential explanations include differences in the population characteristics between the two studies. Although ACS was dominant in their study (30 with stable and 20 with unstable angina), the majority of our study consisted of stable AP (78/86). Of note, Nakazawa et al. 4 reported the incidence of neoatherosclerosis was 41% of DES lesions with a follow-up time of 2-6 years in the autopsy cases with .70% of deaths being not stent related.
Speckled pattern image and peri-strut low intensity area A Speckled pattern image was frequently observed in the early phase. A previous histopathological study demonstrated that restenotic tissue with the speckled pattern image exhibited myxomatous neointima tissue. 14 Chung et al. 21 previously reported that myxoid tissue containing the extracellular matrix enriched with proteoglycans was found in 69% of patients with BMS E-ISR and decreased over time after BMS stenting. DESs suppress the immunological response of the treated artery compared with BMSs. Therefore, in accordance with previous reports, the delayed arterial healing process of the DES, which includes replacement of the extracellular matrix by matured smooth muscle cells or collagen deposition, might contribute to this speckled pattern image. A PLIA was also observed more frequently in the early phase and similarly to the results of speckled pattern OCT images. Teramoto et al. 15 reported that a PLIA was more frequently observed with DESs than BMS, and the regions corresponding with the PLIA were distinguished as hypocellular regions, suggesting the presence of fibrinoid or proteoglycans and considered as a reflection of delayed arterial healing of the DES. This result of PLIA might support our hypothesis that speckled pattern images were caused by delayed arterial healing of the DES.
Limitations
OCT has intrinsic limitations in the qualitative analysis of restenotic tissue. Inter-/intra-observer variability was generally good; however, the differentiation of the layered or speckled pattern image was difficult in some cases. In such cases, a consensus was reached and used as the final decision. In addition, there were few data about the correlation of OCT images of DES restenotic tissue and histological findings. 14 Therefore, OCT findings of intimal tissue should be interpreted with caution. 22 Secondly, there was a significant difference of the stent type between groups. Only two patients with ISR of the TAXUS stent were enrolled in the VL-ISR group. The Cypher stent was approved 8 years ago (August 2004), whereas the TAXUS stent was only 5 years ago (March 2007) in Japan. This difference of approval time may contribute to the difference of patient numbers, especially in the VL-ISR group. In addition, the present study focused on the first generation DESs, although second generation DESs are commonly used in current practice. Further studies are needed to examine whether this study finding is applicable to other DESs, especially second generation DESs. Thirdly, our findings are based on observations in a relatively small number of patients. Fourthly, VL-ISR cannot be classified as accurately as E-ISR and L-ISR: the moment of atherosclerotic progression and lesion appearance could be not the same as the moment of angiographic assessment in VL-ISR. Fifthly, this study was not designed as a serial analysis. Therefore, it is uncertain whether differences of OCT images at different time-points relate to differences of the ISR mechanism or time course of neointimal tissue formation.
Conclusion
The OCT morphological characteristics of DES restenotic tissue were different over a prespecified time course. OCT images in Incidence of disrupted intima with visible cavity, intraluminal materials (with/without shadowing), microvessels and peri-strut low intensity area in each OCT image pattern at the minimum lumen area site. TCFA, thin-cap fibroatheroma.
DES E-ISR might be associated with delayed arterial healing, and neoatherosclerosis might contribute to the DES late catch-up phenomenon including L-ISR and VL-ISR.
